Embecta Corp. (JX7)
XFRA 
Summary
JX7 Chart
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript
Embecta Corp. ( EMBC ) Q4 2025 Earnings Call November 25, 2025 8:00 AM EST Company Participants Pravesh Khandelwal - VP & Head of Investor Relations Devdatt Kurdikar - President, CEO & Director Jake Elguicze - Senior VP & CFO Conference Call Participants Marie Thibault - BTIG, LLC, Research Division Michael Polark - Wolfe Research, LLC Anthony Petrone - Mizuho Securities USA LLC, Research Division Gracia Mahoney - BofA Securities, Research Division Presentation Operator Welcome, ladies and gentlemen, to Embecta Corp.'s Fiscal Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and a replay will be available on the company's website following the call.
Best Value Stocks to Buy for September 9th
JXN, EMBC and KT made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 9, 2025.
Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript
Embecta Corp. (NASDAQ:EMBC ) Q3 2025 Earnings Conference Call August 8, 2025 8:00 AM ET Company Participants Devdatt Kurdikar - President, CEO & Director Jacob P. Elguicze - Senior VP & CFO Pravesh Khandelwal - VP & Head of Investor Relations Conference Call Participants Anthony Charles Petrone - Mizuho Securities USA LLC, Research Division Gracia Leydon Mahoney - BofA Securities, Research Division Marie Yoko Thibault - BTIG, LLC, Research Division Michael K.
Embecta Corp. (JX7) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Embecta Corp. ever had a stock split?
Embecta Corp. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Devdatt Kurdikar CEO | XFRA Exchange | US29082K1051 ISIN |
| US Country | 2,000 Employees | 5 Dec 2025 Last Dividend | - Last Split | 1 Apr 2022 IPO Date |
Overview
Embecta Corp. stands as a pioneering medical device company with its focus sharply attuned to enhancing the health and wellbeing of individuals battling diabetes. With its roots planted as far back as 1924, Embecta has burgeoned into a flagship enterprise, dedicated to delivering innovative solutions for diabetes management. Operating from its headquarters in Parsippany, New Jersey, the company has marked its presence both in the United States and on an international spectrum, predominantly through wholesalers and distributors. The essence of Embecta's mission revolves around its commitment to supporting people with diabetes through its extensive range of products and digital applications designed for efficacious diabetes management.
Products and Services
- Pen Needles
- Syringes
- Safety Injection Devices
- Digital Applications
Pen needles from Embecta are tailored for ease of use and comfort, meeting the diverse needs of individuals requiring insulin or other injectable diabetes medications. These needles are designed to facilitate a less painful insertion process, enhancing the overall experience of daily diabetes management.
Embecta presents a range of syringes geared towards ensuring accuracy, safety, and comfort during insulin delivery. These syringes are constructed with patient safety in mind, incorporating features that aim to minimize injection-related anxiety and complications.
The company's Safety Injection Devices are developed with cutting-edge technology to mitigate the risks associated with needlestick injuries, a concern for both healthcare providers and patients. These devices embody the essence of Embecta's commitment to safety in diabetes care.
Recognizing the growing need for digital health solutions, Embecta has ventured into providing digital applications designed to assist individuals in managing their diabetes more effectively. These applications offer tools for monitoring blood sugar levels, medication tracking, and personalized insights into one’s diabetes management plan, ultimately aiming to empower users with control over their health.
Contact Information
